A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with breast cancer.

Even patients with stroke with excellent functional recovery can experience significant, adverse nonmotor outcomes 6 months ...

A new study raises safety concerns about long-term use of melatonin supplements by those with insomnia, noting that it ...

LANZHOU -- Chinese researchers have revealed the heart-protective effect of nicotinamide — a derivative of B vitamins — in ...

In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and ...

The TL1a inhibitor duvakitug was effective at 14 weeks in patients who had previous exposure to conventional and advanced ...

A study by University of Manchester scientists has revealed some of the mechanisms which may explain why older mice are more ...

Drilling for minerals deep in the ocean could have immense consequences on the tiny animals at the core of the vast ocean ...

The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older. Previously, ...

There was no significant decrease in pulmonary exacerbations over 52 weeks among adults with bronchiectasis receiving hypertonic saline or carbocysteine with standard care, according to data published ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...